US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amgen

277.90

-0.5000-0.18%

Post-market: 277.00-0.9000-0.32%18:34 EDT

Volume:2.68M

Turnover:746.81M

Market Cap:149.41B

PE:36.76

High:283.60

Open:279.91

Low:276.42

Close:278.40

Loading ...

Overview Company News Filings

Here's How to Play JNJ Stock as it Announces $55B US Investment Plan

3 of Goldman Sachs' best investing tips for currently volatile markets

FDA Accepts RDY & ALVO's Prolia & Xgeva Biosimilar BLA for Review

Amgen Rises Almost 22% YTD: Should You Buy, Hold or Sell the Stock?

Is Amgen Inc. (AMGN) a Best Biotech Stock According to Billionaires?

Amgen (AMGN) Exceeds Market Returns: Some Facts to Consider

Amgen Inc. Stock Outperforms Competitors On Strong Trading Day

AMGN Posts Upbeat Data on Uplizna From Myasthenia Gravis Study

Beat the Market the Zacks Way: Amgen, DRDGOLD, Anavex in Focus

BRIEF-CMS Announces Manufacturer Participation in Second Cycle of Medicare Drug Price Negotiation

Regeneron Shares Fall After US Appeals Court Denies Request for Stay on Eylea Biosimilars

MT Newswires Live

BMO says Eylea court decision ‘modest negative’ for Regeneron

Amgen data ‘muddies’ outlook for Cartesian, says Oppenheimer

Amgen (NasdaqGS:AMGN) Announces Promising MINT Trial Data For UPLIZNA In Generalized Myasthenia Gravis

Simply Wall St.

Amgen's Uplizna Shows Improved Symptoms In Patients With Muscle Weakness Disorder Over One Year

Exelixis (EXEL) Up 13.4% Since Last Earnings Report: Can It Continue?

BRIEF-Uplizna Significantly Improves Generalized Myasthenia Gravis Symptoms In Acetylcholine Receptor Autoantibody-Positive Patients Over 52 Weeks

Amgen Says Phase 3 Data Support Uplizna's Efficacy in Generalized Myasthenia Gravis

MT Newswires Live

Amgen Inc: No New Safety Signals Were Identified From Study

THOMSON REUTERS

Amgen: Uplizna Regulatory Filing Activities Underway, Submission to Be Complete in H1 2025

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/AMGN/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AMGN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AMGN\",,,,,undefined,":{"symbol":"AMGN","market":"US","secType":"STK","nameCN":"Amgen","latestPrice":277.9,"timestamp":1745438400000,"preClose":278.4,"halted":0,"volume":2679592,"hourTrading":{"tag":"盘后","latestPrice":277,"preClose":277.9,"latestTime":"18:34 EDT","volume":113952,"amount":31667306.380799998,"timestamp":1745447666616},"delay":0,"floatShares":536285636,"shares":537650624,"eps":7.56,"marketStatus":"Post-Mkt","change":-0.5,"latestTime":"04-23 19:01:50 EDT","open":279.91,"high":283.6,"low":276.42,"amount":746814509.3395201,"amplitude":0.02579,"askPrice":278.12,"askSize":28,"bidPrice":276.55,"bidSize":100,"shortable":3,"etf":0,"ttmEps":7.56,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1745452800000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":423288000000,"exchange":"NASDAQ","adjPreClose":278.4,"dividendRate":0.032386,"preHourTrading":{"tag":"盘前","latestPrice":279.61,"preClose":278.4,"latestTime":"09:29 EDT","volume":3680,"amount":1028319.6960000001,"timestamp":1745414999999},"postHourTrading":{"tag":"盘后","latestPrice":277,"preClose":277.9,"latestTime":"18:34 EDT","volume":113952,"amount":31667306.380799998,"timestamp":1745447666616},"volumeRatio":0.99197,"impliedVol":0.3881,"impliedVolPercentile":0.796},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AMGN\",,,,,undefined,":{"symbol":"AMGN","floatShares":536285636,"roa":"6.40%","roe":"67.55%","lyrEps":7.616387,"volumeRatio":0.99197,"shares":537650624,"dividePrice":9,"high":283.6,"amplitude":0.02579,"preClose":278.4,"low":276.42,"week52Low":253.3,"pbRate":"25.42","psRate":"4.47","week52High":346.85,"institutionHeld":0.6644,"latestPrice":277.9,"committee":0.5625,"eps":7.56,"divideRate":0.032386,"volume":2679592,"delay":0,"ttmEps":7.56,"open":279.91,"prevYearClose":260.64,"prevWeekClose":277.29,"prevMonthClose":311.55,"prevQuarterClose":311.55,"fiveDayClose":295.3,"twentyDayClose":306.86,"sixtyDayClose":282.95,"earningDate":1746028800000,"earningTime":"盘后"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AMGN\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2521830728","title":"Here's How to Play JNJ Stock as it Announces $55B US Investment Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2521830728","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521830728?lang=en_us&edition=fundamental","pubTime":"2025-03-24 18:31","pubTimestamp":1742812260,"startTime":"0","endTime":"0","summary":"Last week, J&J JNJ announced plans to invest more than $55 billion over the next four years to expand its manufacturing footprint in the United States as the Trump administration considers imposing tariffs on pharmaceuticals.This represents a 25% increase in investmentcompared to the previous four years. The investments begin with the groundbreaking of a high-tech facility in North Carolina. In addition, the company will build three new advanced manufacturing facilities and expand several existing plans across its Innovative Medicine and MedTech businesses.The massive U.S. investments shift focus to J&J stock. However, investors should not make their investment decisions based on just on-off news. Let’s analyze the company’s strengths and weaknesses to gain a better understanding of how to play the stock.J&J lost U.S. patent exclusivity of its blockbuster drug, Stelara, in 2025. Stelara generated sales of $10.36 billion in 2024. The launch of generics is expected to significantly erode","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heres-play-jnj-stock-announces-103100843.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BFTCPJ56.SGD","ITCI","LU2505996509.AUD","IE00BJT1NW94.SGD","LU0203347892.USD","LU1585245621.USD","IE00B2B36J28.USD","LU1061106388.HKD","LU1066051498.USD","BK4581","LU0320765992.SGD","LU1221951129.SGD","IE0002141913.USD","LU1430594728.SGD","LU1778281490.HKD","LU2430703178.SGD","BK4568","LU1057294990.SGD","LU0203345920.USD","LU0053671581.USD","IE00B19Z3B42.SGD","LU0234570918.USD","LU2112291526.USD","LU2468319806.SGD","BK4585","LU0792757196.USD","SG9999001440.SGD","LU2430703095.HKD","IE00BSNM7G36.USD","LU2592432038.USD","LU1066051225.USD","LU1244550494.USD","IE00BJJMRZ35.SGD","JNJ","IE00B7SZLL34.SGD","LU1032466523.USD","LU2242652126.USD","LU2602419157.SGD","IE00B42XCP33.USD","LU1718418525.SGD","LU1674673691.USD","BK4559","AMGN","LU2129689431.USD","SG9999002224.SGD","BK4533","KVUE","LU0289739699.SGD","LU0882574055.USD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2521823782","title":"3 of Goldman Sachs' best investing tips for currently volatile markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2521823782","media":"Yahoo Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521823782?lang=en_us&edition=fundamental","pubTime":"2025-03-21 21:30","pubTimestamp":1742563852,"startTime":"0","endTime":"0","summary":"Volatile times in markets require extra precision, says Goldman Sachs chief US equity strategist David Kostin.In a new note on Friday, Kostin offered three recommendations for investors dealing with topsy-turvy markets ahead of the spring:. Own US stocks \"insensitive\" to drivers of ongoing market volatility.Favor stocks with a high percentage of US sales and avoid companies with outsized overseas sales.The markets have whipsawed this year, especially in March as investors digest a flurry of tariff headlines and slowing economic data. Warnings on demand this month from big companies Nike , FedEx , and Delta  have added to the investor angst.\"The current environment, however, is adding uncertainty to demand. We continue to work closely with our customers to help them adapt to this evolving market,\" FedEx CEO Raj Subramaniam said on a Thursday evening earnings call.Consumer staples — companies that sell soda to those offering healthcare services and energy — continue to attract their fair","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-of-goldman-sachs-best-investing-tips-for-currently-volatile-markets-133052214.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["XLU","LU1823568750.SGD","AMGN","LLY","NVDA","LU2087625088.SGD","KR","GS","LU1941712348.USD","NVD","NKE","NVD2.UK","SCHW","IE00BQXX3C00.GBP","2NVD.UK","IYH","LU1861558580.USD","SG9999001176.SGD","LU2433249047.HKD","NVDY","IE0002141913.USD","DAL","TSLA","LU0128525929.USD","IE00BN8TJ469.HKD","LU0203202063.USD","NVDS.UK","SNVD.UK","NVDU","NVD3.UK","COST","USJW.SI","BK4561","NVDD","FDX","IE0004445239.USD","3NVD.UK","IE0009355771.USD","MRK","GOOGL","NVIW.SI","IE00BFXG0V08.USD","V","CEG","BK4596","DUK","GOOG","TSYW.SI","NVDS"],"gpt_icon":1},{"id":"2520152024","title":"FDA Accepts RDY & ALVO's Prolia & Xgeva Biosimilar BLA for Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2520152024","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520152024?lang=en_us&edition=fundamental","pubTime":"2025-03-19 23:13","pubTimestamp":1742397180,"startTime":"0","endTime":"0","summary":"Dr. Reddy’s LaboratoriesRDY and partner, Alvotech ALVO, announced the FDA’s acceptance of a regulatory filing, seeking the approval of AVT03, a proposed biosimilar of Amgen’s AMGN Prolia  and Xgeva , for review.The biologic license application  was submitted under the 351 pathway, which is the FDA’s biosimilar application process. AVT03 is a human monoclonal antibody developed by Alvotech.Amgen's Prolia treats osteoporosis in postmenopausal women at high risk of fractures, especially when other treatments are ineffective. AMGN’s Xgeva helps prevent fractures, spinal cord compression and the need for bone-related surgery or radiation in patients with multiple myeloma or bone metastases from solid tumors.Both drugs play a crucial role in Amgen’s revenue stream. In 2024, Prolia generated $2.89 billion in sales, reflecting an 8% year-over-year increase. Meanwhile, Xgeva brought in $1.51 billion, marking 5% growth compared with 2023.Year to date, Dr. Reddy’s shares have lost 15.5% compared ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fda-accepts-rdy-alvos-prolia-151300159.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1430594728.SGD","LU2242652126.USD","LU2112291526.USD","BK4557","LU0889565916.HKD","IE00B4R5TH58.HKD","BK4523","LU0109394709.USD","IE00B7SZLL34.SGD","LU2089984988.USD","ALVO","AMGN","BK4139","LU1061106388.HKD","BK4568","RDY","IE0009355771.USD","LU1057294990.SGD","IE00B19Z3581.USD","LU2468319806.SGD","BK4578","LU1023059063.AUD","IE00BZ1G4Q59.USD","SG9999001440.SGD","IE00B3T34201.USD","LU0320765992.SGD","BK4588","LU0058720904.USD","BK4007","BK4599","BK4583","LU0122379950.USD","IE00BFTCPJ56.SGD","LU1571399168.USD","IE00B19Z3B42.SGD","LU2087621335.USD","LU1983299246.USD","BK4581","BK4532","BK4596","IE00BJJMRZ35.SGD","IE0002141913.USD","BK4550","LU1585245621.USD","LU1839511570.USD","LU2242646821.SGD","BK4566","IE00BSNM7G36.USD","BK4585","GILD"],"gpt_icon":0},{"id":"2520989760","title":"Amgen Rises Almost 22% YTD: Should You Buy, Hold or Sell the Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2520989760","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520989760?lang=en_us&edition=fundamental","pubTime":"2025-03-18 23:49","pubTimestamp":1742312940,"startTime":"0","endTime":"0","summary":"Amgen’s AMGN stock has risen 21.7% so far this year compared with an increase of 7% for the industry.However, increased pricing headwinds and competitive pressure are hurting sales of many products. Weakness in some key brands, like Otezla and Lumakras, creates potential revenue headwinds. Sales of best-selling drugs, Prolia and Xgeva, are expected to decline in 2025 due to biosimilar competition.Based on the encouraging data from the phase II study, Amgen expects to launch the phase III MARITIME study on MariTide across obesity, obesity-related conditions and type-II diabetes, with the first studies to begin in the first half of 2025. Amgen expects data readouts from the ongoing phase II study in type II diabetes and pa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amgen-rises-almost-22-ytd-154900941.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2491049909.HKD","IE00B2B36J28.USD","LU1064131342.USD","LU1732800096.USD","LU0198837287.USD","LU2361044865.SGD","LU0320765059.SGD","ABBV","LU1718418525.SGD","LU1804176565.USD","LU0889565916.HKD","LU2361045086.USD","LU0868494617.USD","SG9999001176.SGD","IE0002141913.USD","LU1720051017.SGD","LU2237443465.HKD","BK4566","LU0061475181.USD","IE0002270589.USD","SG9999014914.USD","LU2237443622.USD","BK4532","LU0354030511.USD","LU2237443549.SGD","SG9999015952.SGD","LU0029864427.USD","LU0912757837.SGD","LU2237443978.SGD","SGXZ99366536.SGD","LU0943347566.SGD","IE0009355771.USD","LU2265009873.SGD","IE00B1BXHZ80.USD","LLY","AMGN","SG9999018865.SGD","SGXZ57979304.SGD","LU0154236417.USD","IE00BK4W5L77.USD","LU2361044949.HKD","IE00BJT1NW94.SGD","LU1551013425.SGD","LU0122379950.USD","BK4559","SG9999013999.USD","LU0109394709.USD","LU2468319806.SGD","LU1162221912.USD"],"gpt_icon":1},{"id":"2520636907","title":"Is Amgen Inc. (AMGN) a Best Biotech Stock According to Billionaires?","url":"https://stock-news.laohu8.com/highlight/detail?id=2520636907","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520636907?lang=en_us&edition=fundamental","pubTime":"2025-03-18 07:39","pubTimestamp":1742254769,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Amgen Inc.  stands against other biotech stocks.Although biotech stocks had a “challenging” year in 2024, JPMorgan believes that some of the industry’s companies could see significant growth in the months to come. Senior partner and principal of investments at Novo Holdings, Johan Hueffer, spoke on CNBC on November 28 about his macro outlook for life sciences investments. He claimed that in the past few years, biotechs have had trouble raising funding. Over the past quarter or two, though, that tendency has begun to improve.Flood’s report also emphasized how the biotech sector has recently demonstrated better fundamentals, which have been ascribed to superior clinical outcomes and a more favorable regulatory environment. Goldman’s data shows that hedge funds continue to underinvest in biotechnology despite these tailwinds. Over the previous y","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amgen-inc-amgn-best-biotech-233929271.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1061106388.HKD","BK4566","LU0106831901.USD","BK4599","BK4534","LU2237443895.HKD","LU2242652126.USD","LU2471134952.CNY","IE0034235188.USD","FOMC","USAW.SI","USJW.SI","SG9999001440.SGD","BK4585","TSYW.SI","BK4533","US2Y.BOND","BK4139",".IXIC","US10Y.BOND","LU2750360641.GBP","SQQQ","LU2471134879.HKD","QID","US5Y.BOND","QLD","LU1868836757.USD","AMGN","LU1868836591.USD","IE0002270589.USD","US7Y.BOND","LU0096364046.USD","US12M.BOND","US6M.BOND","LU0122379950.USD","US30Y.BOND","LU1571399168.USD","LU2471134796.USD","PSQ","LU0868494617.USD","LU2750360997.AUD","MNQmain","TQQQ","NVIW.SI","US3Y.BOND","NQmain","LU2471134523.USD","BK4588","BK4550"],"gpt_icon":1},{"id":"2520636186","title":"Amgen (AMGN) Exceeds Market Returns: Some Facts to Consider","url":"https://stock-news.laohu8.com/highlight/detail?id=2520636186","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520636186?lang=en_us&edition=fundamental","pubTime":"2025-03-18 06:00","pubTimestamp":1742248814,"startTime":"0","endTime":"0","summary":"In the latest trading session, Amgen  closed at $317.17, marking a +1.1% move from the previous day. The stock outpaced the S&P 500's daily gain of 0.64%. Meanwhile, the Dow experienced a rise of 0.85%, and the technology-dominated Nasdaq saw an increase of 0.31%.Prior to today's trading, shares of the world's largest biotech drugmaker had gained 7.74% over the past month. This has outpaced the Medical sector's loss of 0.88% and the S&P 500's loss of 7.69% in that time.Investors will be eagerly watching for the performance of Amgen in its upcoming earnings disclosure. It is anticipated that the company will report an EPS of $4.18, marking a 5.56% rise compared to the same quarter of the previous year. Meanwhile, the latest consensus estimate predicts the revenue to be $8.01 billion, indicating a 7.52% increase compared to the same quarter of the previous year.The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the indiv","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amgen-amgn-exceeds-market-returns-220014972.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2242646821.SGD","IE00B2B36J28.USD","LU2112291526.USD","LU2242652126.USD","LU0320765992.SGD","IE00BFTCPJ56.SGD","LU1057294990.SGD","LU0058720904.USD","LU0889565916.HKD","LU0868494617.USD","IE0002141913.USD","BK4566","BK4534","LU1983299246.USD","BK4588","BK4599","LU0289739699.SGD","LU1571399168.USD","IE00BJJMRZ35.SGD","BK4581","BK4585","IE0009355771.USD","BK4533","IE00B4R5TH58.HKD","AMGN","LU1023059063.AUD","LU1061106388.HKD","BK4139","SG9999001440.SGD","IE00BJT1NW94.SGD","LU0122379950.USD","LU0109394709.USD"],"gpt_icon":0},{"id":"2520685830","title":"Amgen Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2520685830","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520685830?lang=en_us&edition=fundamental","pubTime":"2025-03-18 04:34","pubTimestamp":1742243640,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  advanced 1.10% to $317.17 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.64% to 5,675.12 and the Dow Jones Industrial Average  rising 0.85% to 41,841.63.This was the stock's third consecutive day of gains.Amgen Inc. closed 8.56% below its 52-week high of $346.85, which the company achieved on July 25th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson  rose 0.02% to $162.84, Pfizer Inc.  rose 1.28% to $26.05, and AbbVie Inc.  rose 1.27% to $214.47.Trading volume  remained 860,134 below its 50-day average volume of 3.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled March 17, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN"],"gpt_icon":0},{"id":"2520066845","title":"AMGN Posts Upbeat Data on Uplizna From Myasthenia Gravis Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2520066845","media":"Zacks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520066845?lang=en_us&edition=fundamental","pubTime":"2025-03-18 00:05","pubTimestamp":1742227500,"startTime":"0","endTime":"0","summary":"Amgen AMGN reported the latest data from the phase III MINT study that evaluated the rare disease drug Uplizna  for label expansion in generalized myasthenia gravis  indication.Data from the study showed that treatment with Uplizna ‘demonstrated durable and sustained efficacy’ in AChR-positive  gMG patients over 52 weeks. These findings were assessed using the Myasthenia Gravis Activities of Daily Living  scores, a patient-reported tool that measures the impact of the disease’s symptoms on a person's ability to perform daily activities. Patients treated with Uplizna for a year showed a 2.8-point improvement over placebo. Per Amgen, about 72% of AChR+ patients in the Uplizna group had an improvement of three or more points in the MG-ADL score compared to 45% in the placebo group.There was also a change in the Quantitative Myasthenia Gravis  score, a physician assessment tool for quantifying disease severity. 69% of AChR+ patients treated with Uplizna showed an improvement of three or mo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amgn-posts-upbeat-data-uplizna-160500075.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1061106388.HKD","LU0868494617.USD","IE00BJJMRZ35.SGD","AMGN","LU2242652126.USD","CTMX","SG9999001440.SGD","LU1057294990.SGD","BK4139","LU1571399168.USD","BK4534","ANIP","IE00BJT1NW94.SGD","LU2112291526.USD","LU0058720904.USD","ARGX","IE0009355771.USD","LU2242646821.SGD","LU0109394709.USD","BK4505","BK4599","LU0289739699.SGD","BK4007","BK4566","LU0889565916.HKD","BK4588","BK4585","LU0122379950.USD","IE0002141913.USD","BK4581","BK4533","IE00BFTCPJ56.SGD","LU0320765992.SGD","LU1023059063.AUD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","LU1983299246.USD"],"gpt_icon":0},{"id":"2520576772","title":"Beat the Market the Zacks Way: Amgen, DRDGOLD, Anavex in Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2520576772","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520576772?lang=en_us&edition=fundamental","pubTime":"2025-03-17 20:04","pubTimestamp":1742213040,"startTime":"0","endTime":"0","summary":"Last Friday, the three most widely followed benchmark indexes closed a losing week. The S&P 500, the Nasdaq Composite and the Dow Jones Industrial Average declined 2.3%, 2.4% and 3.1%, respectively.For the S&P 500 and the tech-focused Nasdaq, it was four straight weeks of losses. Throughout the week, the Trump administration’s tariff policies continued to influence trading in the markets. Uncertainty around tariff imposition weighed on investor mood even as inflation numbers came in cooler than expected. Consumer Sentiment came in pretty low.In fact, market sentiments have sent investors running for cover toward safe-haven assets like gold. All eyes are firmly set on the Fed’s March meeting on Wednesday, wherein the central bank will declare its policy moves. Currently, it is widely expected that the interest rate level will go untouched.Regardless of market conditions, we, here at Zacks, provide investors with unbiased guidance on how to beat the market.As usual, Zacks Research guided","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/beat-market-zacks-way-amgen-120400574.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SPXU","FDN","LRN","LU1061106388.HKD","SPY","MWA","LU2362541513.USD","COR","IE00BFTCPJ56.SGD","LU0787776722.HKD","LU1721427968.SGD","AMT","DRD","LTH","BK4590","LU1983299246.USD","LU2286300806.USD","CHKP","VOO","LU1165135440.EUR","LU1585245621.USD","ESmain","AMGN","OEF","BK4512","LU1043141396.HKD","IVV","SSO","SG9999004303.SGD","MPLX","SDS","BK4161","MMM",".SPX","IE00BJT1NW94.SGD","BK4216","LU0109394709.USD","BK4581","LU0426417589.USD","LU1559883803.SGD","OEX","LU1121112475.USD","SH","BK4554","AVXL","NOBL","ECDP","LU1894683348.USD","LU0823417653.USD"],"gpt_icon":1},{"id":"2519556273","title":"BRIEF-CMS Announces Manufacturer Participation in Second Cycle of Medicare Drug Price Negotiation","url":"https://stock-news.laohu8.com/highlight/detail?id=2519556273","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519556273?lang=en_us&edition=fundamental","pubTime":"2025-03-15 05:56","pubTimestamp":1741989411,"startTime":"0","endTime":"0","summary":"BRIEF-CMS Announces Manufacturer Participation in Second Cycle of Medicare Drug Price NegotiationMarch 14  - CMS: DEALS SIGNED WITH MANUFACTURERS OF 15 DRUGS COVERED UNDER MEDICARE PART D SELECTED FOR SECOND CYCLE OF MEDICARE DRUG PRICE NEGOTIATION PROGRAM ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250314:nFWN3PX0R5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1162221912.USD","MRK","LU1035773651.USD","03165","LU1496350171.SGD","LU0965508806.USD","LU1894683348.USD","ABBV","LU0058720904.USD","LU2091194634.USD","LU1098665638.USD","IE0002270589.USD","GSK.UK","LU2237443382.USD","LU1732800096.USD","IE00B42XCP33.USD","BK4007","LU1670710661.SGD","IE00BN8TJ469.HKD","SG9999014559.SGD","LU0823399737.USD","LU0047473722.EUR","IE00BWDBJ516.SGD","IE00BFTCPJ56.SGD","LU1228905540.USD","LU1015430645.USD","LU0211326755.USD","AMGN","LU1941712348.USD","LU0456855351.SGD","LU1814569148.SGD","AZN.UK","LU0738911758.USD","LU2242652126.USD","LU0265550359.USD","BMY","SG9999014575.USD","LU2089284900.SGD","BK4516","LU0306806265.USD","LU1116320737.USD","LU0889566641.SGD","BK4568","LU0795875086.SGD","LU0661504455.SGD","SGXZ57979304.SGD","LU2237443622.USD","LU1917777945.USD","LU0949170772.SGD"],"gpt_icon":0},{"id":"2519380856","title":"Regeneron Shares Fall After US Appeals Court Denies Request for Stay on Eylea Biosimilars","url":"https://stock-news.laohu8.com/highlight/detail?id=2519380856","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519380856?lang=en_us&edition=fundamental","pubTime":"2025-03-15 01:02","pubTimestamp":1741971725,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals  shares were down over 2% in recent Friday trading after multiple media reports said that a US appeals court denied the company's request to block sales of biosimilar versions of its drug Eylea.The company was seeking to prevent Amgen  and others from marketing copy-cat versions of its treatment for wet macular degeneration but the US Court of Appeals for the Federal Circuit upheld an earlier decision to deny Regeneron's motion for patent infringement.The earlier motion was denied on grounds that the company could not prove Amgen infringed on Regeneron's patents covering a vial containing Eylea, according to reports.Price: 664.59, Change: -16.02, Percent Change: -2.35","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2362541513.USD","LU2023250504.SGD","BK4581","LU1983299246.USD","IE00BJJMRZ35.SGD","LU0114720955.EUR","LU0109394709.USD","LU0122379950.USD","LU2242652126.USD","LU1974910355.USD","LU2089984988.USD","LU2362540622.SGD","LU2468319806.SGD","LU0889565916.HKD","LU2112291526.USD","LU2362541273.HKD","SG9999001440.SGD","BK4534","LU0823416689.USD","IE00B2B36J28.USD","BK4588","LU0053666078.USD","IE00BFTCPJ56.SGD","LU0058720904.USD","LU0289739699.SGD","LU1917777945.USD","AMGN","LU1023059063.AUD","BK4585","LU0320765992.SGD","LU1061106388.HKD","IE00BJT1NW94.SGD","LU2106854487.HKD","BK4139","LU1571399168.USD","IE0002141913.USD","IE0009355771.USD","LU2242646821.SGD","LU2237438978.USD","REGN","LU0868494617.USD","BK4599","BK4566","LU1057294990.SGD","BK4533","LU0882574055.USD","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2519876703","title":"BMO says Eylea court decision ‘modest negative’ for Regeneron","url":"https://stock-news.laohu8.com/highlight/detail?id=2519876703","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519876703?lang=en_us&edition=fundamental","pubTime":"2025-03-15 00:35","pubTimestamp":1741970108,"startTime":"0","endTime":"0","summary":"BMO Capital says that today’s appeals court decision to affirm the denial of Regeneron’s (REGN) preliminary injunction against Amgen (AMGN) in its ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bmo-says-eylea-court-decision-modest-negative-for-regeneron?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bmo-says-eylea-court-decision-modest-negative-for-regeneron?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["REGN","BK4139","BK4207","LU2362541273.HKD","LU1974910355.USD","LU0823416689.USD","IE0002141913.USD","LU2023250504.SGD","LU2089984988.USD","LU2362541513.USD","LU1057294990.SGD","LU0882574055.USD","BK4599","BK4566","LU0053666078.USD","LU2362540622.SGD","LU0889565916.HKD","BK4581","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU0122379950.USD","BK4534","LU1917777945.USD","LU0868494617.USD","BMO","LU1571399168.USD","BK4533","IE00BJT1NW94.SGD","LU0289739699.SGD","LU2106854487.HKD","LU0058720904.USD","IE00BFTCPJ56.SGD","BK4585","SG9999001440.SGD","LU2242646821.SGD","IE0009355771.USD","LU2237438978.USD","LU2242652126.USD","LU1983299246.USD","LU2468319806.SGD","IE00B4R5TH58.HKD","LU1023059063.AUD","LU0109394709.USD","BK4588","LU0320765992.SGD","LU0114720955.EUR","LU2112291526.USD","LU1061106388.HKD","AMGN"],"gpt_icon":0},{"id":"2519387387","title":"Amgen data ‘muddies’ outlook for Cartesian, says Oppenheimer","url":"https://stock-news.laohu8.com/highlight/detail?id=2519387387","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519387387?lang=en_us&edition=fundamental","pubTime":"2025-03-15 00:15","pubTimestamp":1741968914,"startTime":"0","endTime":"0","summary":"Oppenheimer reiterates a Perform rating on Cartesian Therapeutics  without a price target following the company’s Q4 report. The company’s Phase 3 trial in myasthenia gravis remains on track to start by mid-year, the analyst tells investors in a research note. The firm thinks the trial has a “decent chance at working,” but does not currently view Descartes-08 as a commercially viable therapy. Just today, Amgen  announced updated Uplizna results showing a deepening of responses six months after a single repeat infusion, Opco points out. It believes extrapolating from Cartesian’s Phase 2, Descartes-08 would likely need six additional infusions to show a similar benefit. The Uplizna study “muddies” commercial outlook for Cartesian, the firm contends.Discover stocks' market position with detailed  competitor analyses.Read More on RNAC:Questions or Comments about the article?Cartesian Therapeutics reports FY24 EPS  vs.  last year","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/amgen-data-muddies-outlook-cartesian-161514365.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amgen-data-muddies-outlook-cartesian-161514365.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1061106388.HKD","LU1057294990.SGD","SG9999001440.SGD","LU1571399168.USD","BK4581","LU0058720904.USD","RNAC","IE00BFTCPJ56.SGD","BK4139","OPY","LU0122379950.USD","LU0109394709.USD","LU2112291526.USD","LU0289739699.SGD","LU0868494617.USD","LU1023059063.AUD","IE0009355771.USD","LU2242652126.USD","BK4585","BK4566","IE00BJJMRZ35.SGD","LU0889565916.HKD","AMGN","LU1983299246.USD","BK4534","LU2242646821.SGD","IE00B2B36J28.USD","LU0320765992.SGD","BK4599","BK4127","IE00BJT1NW94.SGD","BK4533","IE00B4R5TH58.HKD","BK4588","IE0002141913.USD"],"gpt_icon":0},{"id":"2519850443","title":"Amgen (NasdaqGS:AMGN) Announces Promising MINT Trial Data For UPLIZNA In Generalized Myasthenia Gravis","url":"https://stock-news.laohu8.com/highlight/detail?id=2519850443","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519850443?lang=en_us&edition=fundamental","pubTime":"2025-03-14 01:21","pubTimestamp":1741886479,"startTime":"0","endTime":"0","summary":"Amgen has recently garnered attention due to promising Phase 3 MINT trial results for UPLIZNA in treating generalized myasthenia gravis, likely influencing its 14% price increase over the last quarter. These findings, emphasizing the drug's efficacy, coincide with Amgen's Q4 2024 earnings report, which showed a rise in revenue yet a decline in net income, reflecting a mixed financial performance. Despite the broader stock market experiencing declines, with the S&P 500 and Nasdaq suffering substantial drops, Amgen's significant focus on product development has potentially bolstered investor confidence. Key product developments, like the FDA approval for LUMAKRAS and the promising results from trials like WAYPOINT for TEZSPIRE and the ROCKET trial with Kyowa Kirin, may have mitigated investor concerns, helping to support Amgen's share price. The company's announcement of ongoing acquisition efforts could also contribute to optimistic market sentiment.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amgen-nasdaqgs-amgn-announces-promising-172119931.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0289739699.SGD","AMGN","LU0122379950.USD","BK4139","SG9999001440.SGD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","LU1023059063.AUD","LU0868494617.USD","MINT","LU1057294990.SGD","IE00BFTCPJ56.SGD","BK4533","BK4581","IE0009355771.USD","LU1571399168.USD","LU0889565916.HKD","BK4585","IE00BJJMRZ35.SGD","LU1061106388.HKD","LU0320765992.SGD","BK4599","LU2242652126.USD","BK4534","LU2112291526.USD","BK4588","IE00BJT1NW94.SGD","BK4566","LU0109394709.USD","LU2242646821.SGD","LU1983299246.USD","BK4550","IE0002141913.USD","LU0058720904.USD"],"gpt_icon":0},{"id":"2519191856","title":"Amgen's Uplizna Shows Improved Symptoms In Patients With Muscle Weakness Disorder Over One Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2519191856","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519191856?lang=en_us&edition=fundamental","pubTime":"2025-03-13 23:36","pubTimestamp":1741880186,"startTime":"0","endTime":"0","summary":"On Thursday, AmgenInc  announced new data from the Phase 3 MINT trial of Uplizna for adult patients with generalized myasthenia gravis , a chronic autoimmune disease that causes muscle weakness.It affects the muscles used for breathing, swallowing, facial expressions, and movement.The results demonstrated the durable and sustained efficacy of Uplizna in patients with acetylcholine receptor autoantibody-positive  gMG with two doses a year following an initial loading dose.The trial demonstrated continued improvement in the efficacy of Uplizna compared to placebo as measured by the change in baseline of Myasthenia Gravis Activities of Daily Living  score in the AChR+ subpopulation through week 52.Among the AChR+ patients in the Uplizna group, 72.3% had a ≥3-point improvement in the MG-ADL score, compared to 45.2% in placebo.Also Read: Amgen And Kyowa Kirin’s Rocatinlimab Reduces Eczema Severity In Phase 3 Study. Change from baseline in the Quantitative Myasthenia Gravis  score was also g","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amgens-uplizna-shows-improved-symptoms-153626401.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0889565916.HKD","BK4599","LU0122379950.USD","AMGN","BK4585","IE00B4R5TH58.HKD","LU2242646821.SGD","LU1061106388.HKD","LU1571399168.USD","IE00B2B36J28.USD","BK4566","LU1023059063.AUD","BK4588","LU0868494617.USD","SG9999001440.SGD","LU0109394709.USD","BK4581","IE0002141913.USD","BK4533","IE00BFTCPJ56.SGD","LU0058720904.USD","LU0320765992.SGD","LU2112291526.USD","LU1057294990.SGD","IE00BJJMRZ35.SGD","BK4534","LU1983299246.USD","LU2242652126.USD","IE0009355771.USD","LU0289739699.SGD","BK4139","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"2519850428","title":"Exelixis (EXEL) Up 13.4% Since Last Earnings Report: Can It Continue?","url":"https://stock-news.laohu8.com/highlight/detail?id=2519850428","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519850428?lang=en_us&edition=fundamental","pubTime":"2025-03-13 23:30","pubTimestamp":1741879829,"startTime":"0","endTime":"0","summary":"It has been about a month since the last earnings report for Exelixis . Shares have added about 13.4% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Exelixis due for a pullback?Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers.It turns out, estimates review have trended upward during the past month.At this time, Exelixis has a strong Growth Score of A, though it is lagging a lot on the Momentum Score front with a C. Charting a somewhat similar path, the stock was allocated a grade of B on the value side, putting it in the second quintile for this investment strategy.Exelixis belongs to the Zacks Medical - Biomedical and Genetics industry. Another stock from the same industry, Amgen , has gained 5.9% over the past month. More than a month has passed since the company","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exelixis-exel-13-4-since-153029170.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AMGN","EXEL"],"gpt_icon":0},{"id":"2519682853","title":"BRIEF-Uplizna Significantly Improves Generalized Myasthenia Gravis Symptoms In Acetylcholine Receptor Autoantibody-Positive Patients Over 52 Weeks","url":"https://stock-news.laohu8.com/highlight/detail?id=2519682853","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519682853?lang=en_us&edition=fundamental","pubTime":"2025-03-13 22:52","pubTimestamp":1741877542,"startTime":"0","endTime":"0","summary":"BRIEF-Uplizna Significantly Improves Generalized Myasthenia Gravis Symptoms In Acetylcholine Receptor Autoantibody-Positive Patients Over 52 WeeksMarch 13 (Reuters) - Amgen Inc AMGN.O:UPLIZNA (INEBILI","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nFWN3PW1E1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","IE00BFTCPJ56.SGD","LU1023059063.AUD","BK4534","IE00BJJMRZ35.SGD","IE0009355771.USD","LU0122379950.USD","LU2242652126.USD","BK4581","BK4585","LU0058720904.USD","LU0289739699.SGD","AMGN","LU2242646821.SGD","BK4599","LU1983299246.USD","IE00BJT1NW94.SGD","BK4588","LU0320765992.SGD","LU1061106388.HKD","BK4566","IE0002141913.USD","LU2112291526.USD","LU1571399168.USD","BK4139","LU0868494617.USD","SG9999001440.SGD","LU1057294990.SGD","IE00B2B36J28.USD","LU0889565916.HKD","IE00B4R5TH58.HKD","BK4533"],"gpt_icon":0},{"id":"2519380837","title":"Amgen Says Phase 3 Data Support Uplizna's Efficacy in Generalized Myasthenia Gravis","url":"https://stock-news.laohu8.com/highlight/detail?id=2519380837","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519380837?lang=en_us&edition=fundamental","pubTime":"2025-03-13 21:58","pubTimestamp":1741874303,"startTime":"0","endTime":"0","summary":"Amgen  said Thursday said that a phase 3 trial of its Uplizna drug showed \"durable and sustained efficacy\" in patients with acetylcholine receptor autoantibody-positive generalized myasthenia gravis with just two doses a year following an initial loading dose.The company said the study showed that 72.3% of AChR+ patients treated with Uplizna achieved an improvement of at least 3 points in the Myasthenia Gravis Activities of Daily Living score, compared with 45.2% in placebo.Amgen previously said the trial, which also evaluated muscle-specific kinase autoantibody-positive patients, met its primary endpoint of statistically significant change from baseline in MG-ADL score at week 26 for both the MuSK+ and AChR+ patients taking Uplizna.The company said it expects to complete filing its application for Uplizna in gMG in H1. The US Food and Drug Administration granted Orphan Drug Designation for Uplizna in gMG.The drug is currently approved for the treatment of adults with anti-aquaporin-4 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1023059063.AUD","LU0058720904.USD","BK4533","IE0002141913.USD","LU2112291526.USD","BK4139","SG9999001440.SGD","LU0122379950.USD","LU2242646821.SGD","AMGN","BK4588","LU0320765992.SGD","IE00B2B36J28.USD","BK4585","IE00B4R5TH58.HKD","LU0109394709.USD","LU1061106388.HKD","IE00BJT1NW94.SGD","IE0009355771.USD","IE00BFTCPJ56.SGD","LU0868494617.USD","BK4566","BK4534","LU2242652126.USD","BK4581","BK4599","LU0289739699.SGD","LU1571399168.USD","IE00BJJMRZ35.SGD","LU0889565916.HKD","LU1057294990.SGD","LU1983299246.USD"],"gpt_icon":1},{"id":"2519831547","title":"Amgen Inc: No New Safety Signals Were Identified From Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2519831547","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519831547?lang=en_us&edition=fundamental","pubTime":"2025-03-13 21:00","pubTimestamp":1741870820,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nFWN3PW1E1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","LU1023059063.AUD","LU1061106388.HKD","BK4139","LU0122379950.USD","BK4581","BK4588","LU0320765992.SGD","LU0058720904.USD","BK4599","IE0002141913.USD","LU1057294990.SGD","LU0868494617.USD","LU2112291526.USD","BK4585","SG9999001440.SGD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU2242652126.USD","LU1983299246.USD","LU0109394709.USD","IE00B4R5TH58.HKD","AMGN","LU2242646821.SGD","BK4533","LU1571399168.USD","LU0889565916.HKD","BK4566","LU0289739699.SGD","BK4534"],"gpt_icon":0},{"id":"2519831528","title":"Amgen: Uplizna Regulatory Filing Activities Underway, Submission to Be Complete in H1 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2519831528","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519831528?lang=en_us&edition=fundamental","pubTime":"2025-03-13 21:00","pubTimestamp":1741870820,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nFWN3PW1E1:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0009355771.USD","LU0889565916.HKD","LU1983299246.USD","LU0058720904.USD","BK4588","LU0868494617.USD","LU2242652126.USD","LU1061106388.HKD","BK4581","LU0122379950.USD","BK4599","LU0289739699.SGD","LU2242646821.SGD","BK4533","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","LU0109394709.USD","LU2112291526.USD","IE00BJT1NW94.SGD","LU1571399168.USD","BK4585","AMGN","LU1057294990.SGD","IE00B4R5TH58.HKD","LU1023059063.AUD","BK4566","BK4534","IE0002141913.USD","LU0320765992.SGD","BK4139","SG9999001440.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AMGN\",params:#limit:5,,,undefined,":[{"date":"2025-05-16","symbol":"AMGN","amount":2.38,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-16","defaultRemindTime":1747402200000,"name":"安进","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-06","payableDate":"2025-05-16","currency":"USD","dateTimestamp":1747368000000,"payDate":"2025-06-06"},{"date":"2025-05-01","symbol":"AMGN","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":4.15,"defaultRemindTime":1746129600000,"name":null,"time":"Post Market","dateTimestamp":1746072000000,"actualEps":null},{"date":"2025-02-14","symbol":"AMGN","amount":2.38,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-14","defaultRemindTime":1739543400000,"name":"安进","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-07","payableDate":"2025-02-14","currency":"USD","dateTimestamp":1739509200000,"payDate":"2025-03-07"},{"market":"US","date":"2025-02-04","symbol":"AMGN","fiscalQuarterEnding":"2024/12","expectedEps":5.03,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1738645200000,"reportTimeType":"post","actualEps":5.31},{"date":"2024-11-18","symbol":"AMGN","amount":2.25,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-11-18","defaultRemindTime":1731940200000,"name":"安进","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-09","payableDate":"2024-11-18","currency":"USD","dateTimestamp":1731906000000,"payDate":"2024-12-09"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AMGN\",market:\"US\",,,undefined,":[{"executeDate":"2015-05-12","recordDate":"2015-05-14","paymentDate":"2015-06-05","value":0.79,"currency":"USD"},{"executeDate":"2015-08-13","recordDate":"2015-08-17","paymentDate":"2015-09-08","value":0.79,"currency":"USD"},{"executeDate":"2015-11-12","recordDate":"2015-11-16","paymentDate":"2015-12-07","value":0.79,"currency":"USD"},{"executeDate":"2016-02-11","recordDate":"2016-02-16","paymentDate":"2016-03-08","value":1,"currency":"USD"},{"executeDate":"2016-05-13","recordDate":"2016-05-17","paymentDate":"2016-06-08","value":1,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AMGN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1818,"buy":0.303,"hold":0.4242,"sell":0.0606,"strongSell":0.0303,"meanLabel":"BUY","meanPercent":0.303,"analysts":33,"updateTime":1743566400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AMGN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AMGN","date":"2025-04-22","current":35.976583,"percent":0.853158,"low":14.461306,"twenty":18.692635,"median":20.529224,"eighty":23.218458,"high":184.575512,"avg":24.503224,"sd":10.996652,"marketCap":147144222776},"quantilePoints":[{"date":"2020-04-24","current":17.709326,"twenty":16.173251,"median":20.021146,"eighty":27.690614,"marketCap":138876532714},{"date":"2020-05-01","current":17.703373,"twenty":16.173251,"median":19.844358,"eighty":27.690614,"marketCap":135873384221},{"date":"2020-05-08","current":17.997688,"twenty":16.173251,"median":19.758056,"eighty":27.690614,"marketCap":138132254233},{"date":"2020-05-15","current":18.410036,"twenty":16.173251,"median":19.678876,"eighty":27.690614,"marketCap":141297025239},{"date":"2020-05-22","current":17.35464,"twenty":16.173251,"median":19.453948,"eighty":27.690614,"marketCap":133196858555},{"date":"2020-05-29","current":17.605267,"twenty":16.173251,"median":19.276407,"eighty":27.690614,"marketCap":135120427550},{"date":"2020-06-05","current":17.29639,"twenty":16.173251,"median":19.191037,"eighty":27.690614,"marketCap":132749790532},{"date":"2020-06-12","current":16.700861,"twenty":16.173251,"median":19.018093,"eighty":27.690614,"marketCap":128179108242},{"date":"2020-06-19","current":18.295069,"twenty":16.173251,"median":18.83538,"eighty":27.690614,"marketCap":140414654141},{"date":"2020-06-26","current":17.845932,"twenty":16.173251,"median":18.756042,"eighty":27.690614,"marketCap":136967524383},{"date":"2020-07-02","current":19.792705,"twenty":16.173251,"median":18.678356,"eighty":27.690614,"marketCap":151909008317},{"date":"2020-07-10","current":19.087574,"twenty":16.173251,"median":18.678356,"eighty":27.690614,"marketCap":146497132246},{"date":"2020-07-17","current":19.809566,"twenty":16.173251,"median":18.678356,"eighty":27.690614,"marketCap":152038422745},{"date":"2020-07-24","current":19.006331,"twenty":16.173251,"median":18.678356,"eighty":27.690614,"marketCap":145873590004},{"date":"2020-07-31","current":19.633059,"twenty":16.173251,"median":18.678356,"eighty":26.208899,"marketCap":143301695929},{"date":"2020-08-07","current":19.313692,"twenty":16.173251,"median":18.678356,"eighty":25.555855,"marketCap":140970634704},{"date":"2020-08-14","current":19.235053,"twenty":16.173251,"median":18.678356,"eighty":25.389038,"marketCap":140396654805},{"date":"2020-08-21","current":19.06895,"twenty":16.173251,"median":18.678356,"eighty":25.251226,"marketCap":139184268691},{"date":"2020-08-28","current":20.311112,"twenty":16.173251,"median":18.678356,"eighty":25.251226,"marketCap":148250808328},{"date":"2020-09-04","current":19.932365,"twenty":16.173251,"median":18.678356,"eighty":25.251226,"marketCap":145486333710},{"date":"2020-09-11","current":19.515904,"twenty":16.173251,"median":18.678356,"eighty":25.251226,"marketCap":142446583017},{"date":"2020-09-18","current":19.8778,"twenty":16.173251,"median":18.678356,"eighty":25.251226,"marketCap":145088061943},{"date":"2020-09-25","current":19.564852,"twenty":16.173251,"median":18.678356,"eighty":25.251226,"marketCap":142803856220},{"date":"2020-10-02","current":19.692439,"twenty":16.173251,"median":18.678356,"eighty":25.251226,"marketCap":143735109322},{"date":"2020-10-09","current":18.993522,"twenty":16.173251,"median":18.678356,"eighty":25.251226,"marketCap":138633716542},{"date":"2020-10-16","current":18.914884,"twenty":16.173251,"median":18.678356,"eighty":25.251226,"marketCap":138059736643},{"date":"2020-10-23","current":18.228004,"twenty":16.173251,"median":18.622152,"eighty":25.251226,"marketCap":133046197929},{"date":"2020-10-30","current":17.178408,"twenty":16.173251,"median":18.558779,"eighty":25.251226,"marketCap":126295658687},{"date":"2020-11-06","current":18.344804,"twenty":16.173251,"median":18.499959,"eighty":25.251226,"marketCap":134871002342},{"date":"2020-11-13","current":18.795367,"twenty":16.173251,"median":18.499959,"eighty":25.251226,"marketCap":138183541744},{"date":"2020-11-20","current":17.671731,"twenty":16.173251,"median":18.453164,"eighty":25.251226,"marketCap":129922569140},{"date":"2020-11-27","current":17.801595,"twenty":16.173251,"median":18.422476,"eighty":25.237225,"marketCap":130877325663},{"date":"2020-12-04","current":18.150009,"twenty":16.173251,"median":18.373573,"eighty":25.218618,"marketCap":133438867556},{"date":"2020-12-11","current":18.006684,"twenty":16.173251,"median":18.354522,"eighty":25.218618,"marketCap":132385142368},{"date":"2020-12-18","current":18.092996,"twenty":16.173251,"median":18.315283,"eighty":25.14437,"marketCap":133019706155},{"date":"2020-12-24","current":17.652727,"twenty":16.173251,"median":18.299146,"eighty":25.120802,"marketCap":129782848673},{"date":"2020-12-31","current":18.206231,"twenty":16.173251,"median":18.287026,"eighty":25.01409,"marketCap":133852207271},{"date":"2021-01-08","current":18.884847,"twenty":16.173251,"median":18.276307,"eighty":24.992595,"marketCap":138841392275},{"date":"2021-01-15","current":19.439142,"twenty":16.173251,"median":18.276307,"eighty":24.992595,"marketCap":142916572559},{"date":"2021-01-22","current":20.073414,"twenty":16.173251,"median":18.276307,"eighty":24.992595,"marketCap":147579743142},{"date":"2021-01-29","current":19.117651,"twenty":16.173251,"median":18.276307,"eighty":24.992595,"marketCap":140552967995},{"date":"2021-02-05","current":18.813857,"twenty":16.173251,"median":18.276307,"eighty":24.992595,"marketCap":136663856000},{"date":"2021-02-12","current":18.860755,"twenty":16.173251,"median":18.276307,"eighty":24.992595,"marketCap":137004521711},{"date":"2021-02-19","current":18.421855,"twenty":16.173251,"median":18.276307,"eighty":24.992595,"marketCap":133816355277},{"date":"2021-02-26","current":17.883567,"twenty":16.173251,"median":18.257589,"eighty":24.992595,"marketCap":129906230864},{"date":"2021-03-05","current":18.106992,"twenty":16.167805,"median":18.235488,"eighty":24.995358,"marketCap":131529192400},{"date":"2021-03-12","current":18.316106,"twenty":16.167805,"median":18.219782,"eighty":24.995358,"marketCap":133048191987},{"date":"2021-03-19","current":19.554884,"twenty":16.167805,"median":18.219782,"eighty":24.995358,"marketCap":142046676235},{"date":"2021-03-26","current":20.105099,"twenty":16.173251,"median":18.223893,"eighty":24.992595,"marketCap":146043435605},{"date":"2021-04-01","current":19.811704,"twenty":16.173251,"median":18.223893,"eighty":24.992595,"marketCap":143912215652},{"date":"2021-04-09","current":19.733759,"twenty":16.167805,"median":18.219782,"eighty":24.995358,"marketCap":143346026649},{"date":"2021-04-16","current":20.269611,"twenty":16.167805,"median":18.219782,"eighty":24.995358,"marketCap":147238451393},{"date":"2021-04-23","current":20.374244,"twenty":16.167805,"median":18.219782,"eighty":24.462657,"marketCap":147998510663},{"date":"2021-04-30","current":19.433467,"twenty":16.167805,"median":18.219782,"eighty":22.472953,"marketCap":137686117205},{"date":"2021-05-07","current":20.615013,"twenty":16.167805,"median":18.219782,"eighty":22.472953,"marketCap":146057368781},{"date":"2021-05-14","current":20.385516,"twenty":16.167805,"median":18.219782,"eighty":22.472953,"marketCap":144431381000},{"date":"2021-05-21","current":20.355511,"twenty":16.167805,"median":18.219782,"eighty":22.472953,"marketCap":144218796025},{"date":"2021-05-28","current":19.295607,"twenty":16.167805,"median":18.219782,"eighty":22.472953,"marketCap":136709375428},{"date":"2021-06-04","current":19.207214,"twenty":16.167805,"median":18.219782,"eighty":22.472953,"marketCap":136083111584},{"date":"2021-06-11","current":19.687293,"twenty":16.167805,"median":18.219782,"eighty":22.472953,"marketCap":139484471181},{"date":"2021-06-18","current":19.355617,"twenty":16.167805,"median":18.219782,"eighty":22.472953,"marketCap":137134545378},{"date":"2021-06-25","current":19.679995,"twenty":16.167805,"median":18.219782,"eighty":22.472953,"marketCap":139432761322},{"date":"2021-07-02","current":20.168183,"twenty":16.167805,"median":18.219782,"eighty":22.472953,"marketCap":142891576318},{"date":"2021-07-09","current":19.884352,"twenty":16.167805,"median":18.219782,"eighty":22.472953,"marketCap":140880637367},{"date":"2021-07-16","current":20.108173,"twenty":16.167805,"median":18.219782,"eighty":22.472953,"marketCap":142466406368},{"date":"2021-07-23","current":20.08871,"twenty":16.167805,"median":18.219782,"eighty":22.472953,"marketCap":142328513411},{"date":"2021-07-30","current":19.587547,"twenty":16.167805,"median":18.219782,"eighty":22.457521,"marketCap":138777769778},{"date":"2021-08-06","current":22.74473,"twenty":16.167805,"median":18.219782,"eighty":22.57985,"marketCap":130691219042},{"date":"2021-08-13","current":22.698282,"twenty":16.167805,"median":18.219782,"eighty":22.642486,"marketCap":130424328437},{"date":"2021-08-20","current":22.090504,"twenty":16.167805,"median":18.219782,"eighty":22.781098,"marketCap":126932036466},{"date":"2021-08-27","current":22.016385,"twenty":16.167805,"median":18.219782,"eighty":22.781098,"marketCap":126506147201},{"date":"2021-09-03","current":22.371169,"twenty":16.167805,"median":18.219782,"eighty":22.781098,"marketCap":128544737148},{"date":"2021-09-10","current":21.123989,"twenty":16.167805,"median":18.219782,"eighty":22.781098,"marketCap":121378440453},{"date":"2021-09-17","current":21.680378,"twenty":16.167805,"median":18.219782,"eighty":22.781098,"marketCap":124575449201},{"date":"2021-09-24","current":21.110153,"twenty":16.167805,"median":18.219782,"eighty":22.781098,"marketCap":121298941124},{"date":"2021-10-01","current":21.140789,"twenty":16.167805,"median":18.219782,"eighty":22.781098,"marketCap":121474975353},{"date":"2021-10-08","current":20.649626,"twenty":16.167805,"median":18.219782,"eighty":22.781098,"marketCap":118652749159},{"date":"2021-10-15","current":20.539929,"twenty":16.167805,"median":18.219782,"eighty":22.781098,"marketCap":118022433047},{"date":"2021-10-22","current":20.678285,"twenty":16.167805,"median":18.219782,"eighty":22.781098,"marketCap":118817426341},{"date":"2021-10-29","current":20.453951,"twenty":16.167805,"median":18.228004,"eighty":22.781098,"marketCap":117528401500},{"date":"2021-11-05","current":21.467169,"twenty":16.213995,"median":18.241378,"eighty":22.781098,"marketCap":120409351870},{"date":"2021-11-12","current":21.228165,"twenty":16.235071,"median":18.284301,"eighty":22.781098,"marketCap":119068779023},{"date":"2021-11-19","current":20.694925,"twenty":16.235071,"median":18.293803,"eighty":22.781098,"marketCap":116077837084},{"date":"2021-11-26","current":20.193821,"twenty":16.235071,"median":18.30715,"eighty":22.781098,"marketCap":113267140233},{"date":"2021-12-03","current":20.32939,"twenty":16.235071,"median":18.34249,"eighty":22.781098,"marketCap":114027549200},{"date":"2021-12-10","current":21.177954,"twenty":16.235071,"median":18.368513,"eighty":22.781098,"marketCap":118787146072},{"date":"2021-12-17","current":22.343852,"twenty":16.235071,"median":18.380509,"eighty":22.781098,"marketCap":125326663195},{"date":"2021-12-23","current":22.473396,"twenty":16.235071,"median":18.410036,"eighty":22.781098,"marketCap":126053276208},{"date":"2021-12-31","current":22.591893,"twenty":16.235071,"median":18.45224,"eighty":22.840789,"marketCap":126717929972},{"date":"2022-01-07","current":22.824872,"twenty":16.23631,"median":18.477574,"eighty":22.849998,"marketCap":128024706865},{"date":"2022-01-14","current":23.635276,"twenty":16.23631,"median":18.513296,"eighty":23.200651,"marketCap":132570262694},{"date":"2022-01-21","current":22.868053,"twenty":16.23631,"median":18.544205,"eighty":23.286209,"marketCap":128266911203},{"date":"2022-01-28","current":23.010652,"twenty":16.23631,"median":18.606602,"eighty":23.286209,"marketCap":129066748784},{"date":"2022-02-04","current":22.304687,"twenty":16.23631,"median":18.655211,"eighty":23.286209,"marketCap":125106989493},{"date":"2022-02-11","current":21.607942,"twenty":16.23631,"median":18.655211,"eighty":23.286209,"marketCap":127335600000},{"date":"2022-02-18","current":20.868042,"twenty":16.23631,"median":18.655211,"eighty":23.286209,"marketCap":122975374014},{"date":"2022-02-25","current":21.459762,"twenty":16.23631,"median":18.655211,"eighty":23.286209,"marketCap":126462377871},{"date":"2022-03-04","current":22.015563,"twenty":16.23631,"median":18.655211,"eighty":23.286209,"marketCap":129737710566},{"date":"2022-03-11","current":21.631796,"twenty":16.23631,"median":18.655211,"eighty":23.286209,"marketCap":127476171324},{"date":"2022-03-18","current":22.331272,"twenty":16.23631,"median":18.655211,"eighty":23.286209,"marketCap":131598188662},{"date":"2022-03-25","current":22.571363,"twenty":16.23631,"median":18.655211,"eighty":23.286209,"marketCap":133013043262},{"date":"2022-04-01","current":22.980652,"twenty":16.23631,"median":18.655211,"eighty":23.286209,"marketCap":135424980434},{"date":"2022-04-08","current":22.827838,"twenty":16.23631,"median":18.675145,"eighty":23.286209,"marketCap":134524446808},{"date":"2022-04-14","current":23.008997,"twenty":16.23631,"median":18.74491,"eighty":23.286209,"marketCap":135592016420},{"date":"2022-04-22","current":22.67657,"twenty":16.23631,"median":18.812926,"eighty":23.286209,"marketCap":133633026182},{"date":"2022-04-29","current":21.76657,"twenty":16.23631,"median":18.827241,"eighty":23.286209,"marketCap":124570082376},{"date":"2022-05-06","current":22.075535,"twenty":16.23631,"median":18.885177,"eighty":23.286209,"marketCap":126338284154},{"date":"2022-05-13","current":22.719599,"twenty":16.23631,"median":18.951089,"eighty":23.286209,"marketCap":130024263692},{"date":"2022-05-20","current":23.102304,"twenty":16.255453,"median":19.04876,"eighty":23.286209,"marketCap":132214483417},{"date":"2022-05-27","current":23.826642,"twenty":16.274958,"median":19.084952,"eighty":23.617369,"marketCap":136359874897},{"date":"2022-06-03","current":23.190979,"twenty":16.289356,"median":19.117425,"eighty":23.639199,"marketCap":132721973353},{"date":"2022-06-10","current":22.403167,"twenty":16.298695,"median":19.160317,"eighty":23.639199,"marketCap":128213325919},{"date":"2022-06-17","current":21.909385,"twenty":16.298695,"median":19.21311,"eighty":23.639199,"marketCap":125387408273},{"date":"2022-06-24","current":22.903484,"twenty":16.296564,"median":19.283018,"eighty":23.643122,"marketCap":131076637560},{"date":"2022-07-01","current":22.920285,"twenty":16.296564,"median":19.297643,"eighty":23.643122,"marketCap":131172793548},{"date":"2022-07-08","current":23.193779,"twenty":16.296564,"median":19.345075,"eighty":23.643122,"marketCap":132737999351},{"date":"2022-07-15","current":23.213381,"twenty":16.296564,"median":19.378688,"eighty":23.643122,"marketCap":132850181337},{"date":"2022-07-22","current":22.957622,"twenty":16.296564,"median":19.414847,"eighty":23.643122,"marketCap":131386473521},{"date":"2022-07-29","current":23.099503,"twenty":16.296564,"median":19.434027,"eighty":23.643122,"marketCap":132198457419},{"date":"2022-08-05","current":20.031436,"twenty":16.296564,"median":19.455363,"eighty":23.643122,"marketCap":131726721812},{"date":"2022-08-12","current":20.205516,"twenty":16.296564,"median":19.514299,"eighty":23.643122,"marketCap":132871473831},{"date":"2022-08-19","current":20.406441,"twenty":16.296564,"median":19.546396,"eighty":23.643122,"marketCap":134192753031},{"date":"2022-08-26","current":19.575899,"twenty":16.296564,"median":19.564852,"eighty":23.643122,"marketCap":128731109052},{"date":"2022-09-02","current":19.715814,"twenty":16.296564,"median":19.575899,"eighty":23.643122,"marketCap":129651190114},{"date":"2022-09-09","current":20.148574,"twenty":16.296564,"median":19.62485,"eighty":23.643122,"marketCap":132497022236},{"date":"2022-09-16","current":18.802299,"twenty":16.296564,"median":19.62485,"eighty":23.643122,"marketCap":123643916669},{"date":"2022-09-23","current":18.463086,"twenty":16.296564,"median":19.62485,"eighty":23.643122,"marketCap":121413255024},{"date":"2022-09-30","current":18.335373,"twenty":16.296564,"median":19.62485,"eighty":23.643122,"marketCap":120573413590},{"date":"2022-10-07","current":18.630659,"twenty":16.296564,"median":19.62485,"eighty":23.643122,"marketCap":122515212575},{"date":"2022-10-14","current":20.445487,"twenty":16.296564,"median":19.662154,"eighty":23.643122,"marketCap":134449519839},{"date":"2022-10-21","current":20.494294,"twenty":16.296564,"median":19.692439,"eighty":23.643122,"marketCap":134770478349},{"date":"2022-10-28","current":22.27333,"twenty":16.296564,"median":19.715814,"eighty":23.643122,"marketCap":146469416038},{"date":"2022-11-04","current":21.002802,"twenty":16.296564,"median":19.751016,"eighty":23.643122,"marketCap":143554149582},{"date":"2022-11-11","current":22.250292,"twenty":16.296564,"median":19.786869,"eighty":23.643122,"marketCap":152080745294},{"date":"2022-11-18","current":22.427501,"twenty":16.365772,"median":19.809746,"eighty":23.643122,"marketCap":153291970091},{"date":"2022-11-25","current":22.150368,"twenty":16.426995,"median":19.822432,"eighty":23.643122,"marketCap":151397763910},{"date":"2022-12-02","current":22.288544,"twenty":16.45469,"median":19.848912,"eighty":23.643122,"marketCap":152342199105},{"date":"2022-12-09","current":21.753013,"twenty":16.45469,"median":19.860147,"eighty":23.643122,"marketCap":148681845751},{"date":"2022-12-16","current":20.875555,"twenty":16.45469,"median":19.884352,"eighty":23.643122,"marketCap":142684415476},{"date":"2022-12-23","current":20.603105,"twenty":16.45469,"median":19.906687,"eighty":23.643122,"marketCap":140822224047},{"date":"2022-12-30","current":20.503181,"twenty":16.45469,"median":19.928353,"eighty":23.643122,"marketCap":140139242663},{"date":"2023-01-06","current":21.483687,"twenty":16.590441,"median":19.965546,"eighty":23.643122,"marketCap":146840997491},{"date":"2023-01-13","current":21.212798,"twenty":16.682527,"median":19.983143,"eighty":23.643122,"marketCap":144989477646},{"date":"2023-01-20","current":20.550021,"twenty":16.721559,"median":20.008427,"eighty":23.643122,"marketCap":140459390187},{"date":"2023-01-27","current":19.80137,"twenty":16.721559,"median":20.02698,"eighty":23.643122,"marketCap":135342365601},{"date":"2023-02-03","current":19.966058,"twenty":16.746183,"median":20.031436,"eighty":23.618115,"marketCap":130817613935},{"date":"2023-02-10","current":19.763315,"twenty":16.746183,"median":20.000412,"eighty":23.37844,"marketCap":129489237715},{"date":"2023-02-17","current":19.602763,"twenty":16.746183,"median":19.970426,"eighty":23.220734,"marketCap":128437304526},{"date":"2023-02-24","current":19.042871,"twenty":16.746183,"median":19.965546,"eighty":23.192099,"marketCap":124768887771},{"date":"2023-03-03","current":19.136593,"twenty":16.746183,"median":19.924341,"eighty":23.136275,"marketCap":125382960444},{"date":"2023-03-10","current":18.570996,"twenty":16.746183,"median":19.897391,"eighty":23.100623,"marketCap":121677165353},{"date":"2023-03-17","current":18.727472,"twenty":16.746183,"median":19.88101,"eighty":23.057312,"marketCap":122702399730},{"date":"2023-03-24","current":19.399018,"twenty":16.746183,"median":19.860147,"eighty":23.003935,"marketCap":127102363931},{"date":"2023-03-31","current":19.702191,"twenty":16.751251,"median":19.855159,"eighty":22.967697,"marketCap":129088755536},{"date":"2023-04-06","current":20.6492,"twenty":16.751251,"median":19.853699,"eighty":22.943427,"marketCap":135293559422},{"date":"2023-04-14","current":20.501087,"twenty":16.746183,"median":19.853049,"eighty":22.911511,"marketCap":134323122187},{"date":"2023-04-21","current":19.85044,"twenty":16.746183,"median":19.85044,"eighty":22.884976,"marketCap":130060083231},{"date":"2023-04-28","current":16.217422,"twenty":16.721559,"median":19.847049,"eighty":22.851077,"marketCap":128393331158},{"date":"2023-05-05","current":15.650498,"twenty":16.619261,"median":19.819738,"eighty":22.833912,"marketCap":123904993882},{"date":"2023-05-12","current":15.677495,"twenty":16.45345,"median":19.809566,"eighty":22.820659,"marketCap":124118724520},{"date":"2023-05-19","current":15.133517,"twenty":16.361568,"median":19.786869,"eighty":22.766687,"marketCap":119812052172},{"date":"2023-05-25","current":14.937118,"twenty":16.286094,"median":19.76504,"eighty":22.74473,"marketCap":118257161784},{"date":"2023-06-02","current":14.461306,"twenty":16.209944,"median":19.733759,"eighty":22.720413,"marketCap":114490159296},{"date":"2023-06-09","current":14.899323,"twenty":16.128497,"median":19.705277,"eighty":22.695234,"marketCap":117957938891},{"date":"2023-06-16","current":15.417654,"twenty":16.053341,"median":19.696132,"eighty":22.638526,"marketCap":122061567133},{"date":"2023-06-23","current":15.499993,"twenty":15.947959,"median":19.681816,"eighty":22.610073,"marketCap":122713445578},{"date":"2023-06-29","current":14.936443,"twenty":15.925862,"median":19.665061,"eighty":22.571363,"marketCap":118251818518},{"date":"2023-07-07","current":15.049153,"twenty":15.832389,"median":19.643512,"eighty":22.531662,"marketCap":119144143930},{"date":"2023-07-14","current":15.365011,"twenty":15.72188,"median":19.6181,"eighty":22.477614,"marketCap":121644792390},{"date":"2023-07-21","current":15.740936,"twenty":15.693123,"median":19.569674,"eighty":22.427657,"marketCap":124620991518},{"date":"2023-07-28","current":15.927946,"twenty":15.693123,"median":19.559569,"eighty":22.392535,"marketCap":126101545170},{"date":"2023-08-04","current":15.445982,"twenty":15.662175,"median":19.546912,"eighty":22.349475,"marketCap":123243492780},{"date":"2023-08-11","current":17.568142,"twenty":15.662175,"median":19.515102,"eighty":22.330899,"marketCap":140176203492},{"date":"2023-08-18","current":17.688141,"twenty":15.662175,"median":19.471539,"eighty":22.296255,"marketCap":141133676606},{"date":"2023-08-25","current":17.203452,"twenty":15.662175,"median":19.448065,"eighty":22.272622,"marketCap":137266341068},{"date":"2023-09-01","current":17.184681,"twenty":15.662175,"median":19.433747,"eighty":22.233292,"marketCap":137116568737},{"date":"2023-09-08","current":17.053956,"twenty":15.662175,"median":19.419117,"eighty":22.161428,"marketCap":136073511434},{"date":"2023-09-15","current":17.584231,"twenty":15.662175,"median":19.397163,"eighty":22.143583,"marketCap":140304579776},{"date":"2023-09-22","current":18.060876,"twenty":15.662175,"median":19.361826,"eighty":22.106537,"marketCap":144107727173},{"date":"2023-09-29","current":18.1554,"twenty":15.662175,"median":19.331128,"eighty":22.066846,"marketCap":144861937838},{"date":"2023-10-06","current":17.770598,"twenty":15.662175,"median":19.295561,"eighty":22.014477,"marketCap":141791605059},{"date":"2023-10-13","current":19.108689,"twenty":15.662175,"median":19.274282,"eighty":21.941495,"marketCap":152468232632},{"date":"2023-10-20","current":18.811038,"twenty":15.662175,"median":19.233413,"eighty":21.887336,"marketCap":150093271388},{"date":"2023-10-27","current":18.080987,"twenty":15.661297,"median":19.205363,"eighty":21.874076,"marketCap":144268197527},{"date":"2023-11-03","current":18.857139,"twenty":15.661297,"median":19.156415,"eighty":21.738073,"marketCap":142673110217},{"date":"2023-11-10","current":18.67818,"twenty":15.661297,"median":19.143928,"eighty":21.665824,"marketCap":141319109809},{"date":"2023-11-17","current":19.027609,"twenty":15.661297,"median":19.130889,"eighty":21.60703,"marketCap":143962889263},{"date":"2023-11-24","current":18.777208,"twenty":15.661297,"median":19.117034,"eighty":21.554683,"marketCap":142068359047},{"date":"2023-12-01","current":19.072879,"twenty":15.661297,"median":19.099758,"eighty":21.464157,"marketCap":144305403200},{"date":"2023-12-08","current":19.191006,"twenty":15.66159,"median":19.094134,"eighty":21.416187,"marketCap":145199150505},{"date":"2023-12-15","current":19.545386,"twenty":15.66159,"median":19.088476,"eighty":21.338314,"marketCap":147880392420},{"date":"2023-12-22","current":19.758297,"twenty":15.66159,"median":19.088476,"eighty":21.259918,"marketCap":149491278281},{"date":"2023-12-29","current":20.404104,"twenty":15.661297,"median":19.088441,"eighty":21.252462,"marketCap":154377453668},{"date":"2024-01-05","current":21.44461,"twenty":15.659873,"median":19.088007,"eighty":21.239158,"marketCap":162249922445},{"date":"2024-01-12","current":21.439659,"twenty":15.659873,"median":19.088007,"eighty":21.239158,"marketCap":162212459983},{"date":"2024-01-19","current":21.53798,"twenty":15.658449,"median":19.087574,"eighty":21.236544,"marketCap":162956357441},{"date":"2024-01-26","current":21.946119,"twenty":15.659873,"median":19.088007,"eighty":21.239158,"marketCap":166044334657},{"date":"2024-02-02","current":22.957624,"twenty":15.693123,"median":19.107644,"eighty":21.257534,"marketCap":173697380443},{"date":"2024-02-09","current":23.49222,"twenty":15.737157,"median":19.117425,"eighty":21.291151,"marketCap":157797241260},{"date":"2024-02-16","current":23.063581,"twenty":15.822743,"median":19.136228,"eighty":21.386067,"marketCap":154918076712},{"date":"2024-02-23","current":22.753216,"twenty":15.847249,"median":19.158149,"eighty":21.434001,"marketCap":152833352187},{"date":"2024-03-01","current":21.847651,"twenty":15.913202,"median":19.191006,"eighty":21.459762,"marketCap":146750672660},{"date":"2024-03-08","current":21.770259,"twenty":15.959833,"median":19.219005,"eighty":21.483687,"marketCap":146230831326},{"date":"2024-03-15","current":21.664942,"twenty":16.12361,"median":19.249061,"eighty":21.554683,"marketCap":145523418377},{"date":"2024-03-22","current":22.096582,"twenty":16.253686,"median":19.283018,"eighty":21.60703,"marketCap":148422739631},{"date":"2024-03-28","current":22.842576,"twenty":16.300826,"median":19.295515,"eighty":21.61388,"marketCap":153433581356},{"date":"2024-04-05","current":21.389683,"twenty":16.414703,"median":19.313181,"eighty":21.665989,"marketCap":143674498169},{"date":"2024-04-12","current":21.542073,"twenty":16.600311,"median":19.349043,"eighty":21.665989,"marketCap":144698103270},{"date":"2024-04-19","current":20.981491,"twenty":16.699346,"median":19.377485,"eighty":21.665989,"marketCap":140932675237},{"date":"2024-04-26","current":21.510919,"twenty":16.769106,"median":19.397985,"eighty":21.680102,"marketCap":144488845120},{"date":"2024-05-03","current":184.575512,"twenty":16.808216,"median":19.422101,"eighty":21.712949,"marketCap":149321588807},{"date":"2024-05-10","current":44.599776,"twenty":16.995402,"median":19.435692,"eighty":21.770259,"marketCap":167828957739},{"date":"2024-05-17","current":44.864929,"twenty":17.072959,"median":19.451439,"eighty":21.841268,"marketCap":168826726266},{"date":"2024-05-24","current":43.693126,"twenty":17.148607,"median":19.472589,"eighty":21.874848,"marketCap":164417233098},{"date":"2024-05-31","current":42.909073,"twenty":17.185421,"median":19.485969,"eighty":21.886923,"marketCap":161466842292},{"date":"2024-06-07","current":43.577656,"twenty":17.203452,"median":19.524293,"eighty":21.905008,"marketCap":163982720997},{"date":"2024-06-14","current":42.552686,"twenty":17.226548,"median":19.5505,"eighty":21.95084,"marketCap":160125755562},{"date":"2024-06-21","current":44.176388,"twenty":17.237638,"median":19.559705,"eighty":21.990774,"marketCap":166235746703},{"date":"2024-06-28","current":44.718097,"twenty":17.264247,"median":19.56727,"eighty":22.013753,"marketCap":168274198533},{"date":"2024-07-05","current":44.103685,"twenty":17.28792,"median":19.595155,"eighty":22.019988,"marketCap":165962165010},{"date":"2024-07-12","current":46.343225,"twenty":17.306092,"median":19.640369,"eighty":22.062934,"marketCap":174389554022},{"date":"2024-07-15","current":47.161491,"twenty":17.312123,"median":19.642034,"eighty":22.06387,"marketCap":177468689154},{"date":"2024-08-02","current":47.831499,"twenty":17.425344,"median":19.681816,"eighty":22.072687,"marketCap":179989932206},{"date":"2024-08-09","current":55.739752,"twenty":17.44095,"median":19.696132,"eighty":22.099075,"marketCap":174465424441},{"date":"2024-08-16","current":55.859922,"twenty":17.469792,"median":19.715814,"eighty":22.136606,"marketCap":174841554895},{"date":"2024-08-23","current":55.712285,"twenty":17.498294,"median":19.751016,"eighty":22.151416,"marketCap":174379451766},{"date":"2024-08-30","current":56.824711,"twenty":17.540235,"median":19.767412,"eighty":22.175099,"marketCap":177861345112},{"date":"2024-09-06","current":55.683101,"twenty":17.557137,"median":19.799964,"eighty":22.228507,"marketCap":174288105799},{"date":"2024-09-13","current":56.661624,"twenty":17.589141,"median":19.811704,"eighty":22.254241,"marketCap":177350882353},{"date":"2024-09-20","current":57.672764,"twenty":17.62317,"median":19.842183,"eighty":22.290172,"marketCap":180515751459},{"date":"2024-09-27","current":54.780113,"twenty":17.658153,"median":19.853049,"eighty":22.306711,"marketCap":171461754102},{"date":"2024-10-04","current":54.502007,"twenty":17.691823,"median":19.858561,"eighty":22.335251,"marketCap":170591280765},{"date":"2024-10-11","current":55.108004,"twenty":17.709492,"median":19.880203,"eighty":22.355641,"marketCap":172488052912},{"date":"2024-10-18","current":55.162939,"twenty":17.751204,"median":19.888267,"eighty":22.404477,"marketCap":172659998262},{"date":"2024-10-25","current":54.194716,"twenty":17.790294,"median":19.912671,"eighty":22.42797,"marketCap":169629461461},{"date":"2024-10-31","current":40.082473,"twenty":17.803862,"median":19.924341,"eighty":22.47144,"marketCap":169548862078},{"date":"2024-11-08","current":40.90713,"twenty":17.821106,"median":19.961208,"eighty":22.516807,"marketCap":173037158860},{"date":"2024-11-15","current":37.605688,"twenty":17.856996,"median":19.969451,"eighty":22.565045,"marketCap":159072058717},{"date":"2024-11-22","current":36.839418,"twenty":17.892069,"median":20.000365,"eighty":22.606957,"marketCap":155830736397},{"date":"2024-11-29","current":35.946071,"twenty":17.930878,"median":20.024597,"eighty":22.615184,"marketCap":152051881355},{"date":"2024-12-06","current":34.86084,"twenty":17.946609,"median":20.061442,"eighty":22.646497,"marketCap":147461351900},{"date":"2024-12-13","current":34.826529,"twenty":17.990315,"median":20.07456,"eighty":22.696758,"marketCap":147316218065},{"date":"2024-12-20","current":33.191057,"twenty":18.022342,"median":20.08651,"eighty":22.722857,"marketCap":140398171920},{"date":"2024-12-27","current":33.443939,"twenty":18.038027,"median":20.106636,"eighty":22.744289,"marketCap":141467862039},{"date":"2025-01-03","current":32.948341,"twenty":18.067285,"median":20.129407,"eighty":22.764389,"marketCap":139371484419},{"date":"2025-01-10","current":33.574828,"twenty":18.089037,"median":20.168183,"eighty":22.793417,"marketCap":142021520743},{"date":"2025-01-17","current":34.238166,"twenty":18.115721,"median":20.202262,"eighty":22.825636,"marketCap":144827441557},{"date":"2025-01-24","current":35.311961,"twenty":18.151744,"median":20.220894,"eighty":22.841424,"marketCap":149369593067},{"date":"2025-01-31","current":36.092209,"twenty":18.184227,"median":20.272071,"eighty":22.848497,"marketCap":152670043986},{"date":"2025-02-07","current":39.097276,"twenty":18.207176,"median":20.311112,"eighty":22.868053,"marketCap":159907860000},{"date":"2025-02-14","current":39.029607,"twenty":18.258908,"median":20.34291,"eighty":22.909084,"marketCap":159631092749},{"date":"2025-02-21","current":39.131899,"twenty":18.295069,"median":20.358512,"eighty":22.924019,"marketCap":160049468667},{"date":"2025-02-28","current":40.168219,"twenty":18.344804,"median":20.383677,"eighty":22.957622,"marketCap":164288015668},{"date":"2025-03-07","current":41.74437,"twenty":18.403786,"median":20.411675,"eighty":22.987154,"marketCap":170734474984},{"date":"2025-03-14","current":41.063998,"twenty":18.453393,"median":20.431472,"eighty":23.022962,"marketCap":167951753379},{"date":"2025-03-21","current":41.379229,"twenty":18.487531,"median":20.449719,"eighty":23.069432,"marketCap":169241045242},{"date":"2025-03-28","current":40.161652,"twenty":18.525885,"median":20.469063,"eighty":23.106687,"marketCap":164261155421},{"date":"2025-04-04","current":40.697543,"twenty":18.578378,"median":20.487065,"eighty":23.140218,"marketCap":166452951588},{"date":"2025-04-11","current":36.992729,"twenty":18.608491,"median":20.500272,"eighty":23.182374,"marketCap":151300262099},{"date":"2025-04-17","current":37.154419,"twenty":18.67818,"median":20.508936,"eighty":23.204669,"marketCap":151961572367},{"date":"2025-04-22","current":35.976583,"twenty":18.692635,"median":20.529224,"eighty":23.218458,"marketCap":147144222776}],"updateTime":1745424710311}}}